Rivastigmine in Parkinson's disease dementia: profile report.
Siddiqui
M Asif A
MA
Wolters Kluwer Health | Adis, Auckland, New Zealand. demail@adis.co.nz
Wagstaff
Antona J
AJ
D000368:Aged; D003704:Dementia / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy*; D048448:Phenylcarbamates / Q000627:therapeutic use*; D000068836:Rivastigmine
D018696:Neuroprotective Agents; D048448:Phenylcarbamates; D000068836:Rivastigmine